Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19

Analysis of the Consumption of Medicinal Products Associated with a High Risk of Drug-Induced Liver Injury in Patients with COVID-19

INTRODUCTION. The risk of liver damage correlates with the severity of COVID-19. However, a growing number of studies have shown an association between liver function impairment and combinations of medicinal products used to treat COVID-19.AIM. The study aimed to analyse the annual consumption of me...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Petrov, A. Yu. Ryazanova, N. S. Tokareva
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-10-01
Series:Безопасность и риск фармакотерапии
Subjects:
pharmacoepidemiological study
drug-induced liver injury
covid-19
alanine transaminase
hepatotoxicity
adverse drug reactions
antimicrobials
nsaids
omeprazole
favipiravir
remdesivir
atc/ddd analysis
Online Access:https://www.risksafety.ru/jour/article/view/396
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.risksafety.ru/jour/article/view/396

Similar Items